DOI: 10.1002/chem.201404381
Communication
&
Copper Catalysis
CuI-Catalyzed Sequential Diamination and Dehydrogenation of
Terminal Olefins: A Facile Approach to Imidazolinones
Yingguang Zhu and Yian Shi*[a]
Abstract: Diamination of olefins presents a powerful strat-
egy to access vicinal diamines. During the last decade,
metal-catalyzed diamination of olefins has received con-
siderable attention. This study describes an efficient se-
quential diamination and dehydrogenation process of ter-
minal olefins with CuBr as catalyst and di-tert-butyldiaziri-
dinone as nitrogen source, providing a facile and viable
approach to a variety of imidazolin-2-ones, which are im-
portant structural motifs present in various biologically
active molecules.
Diamination of olefins provides a straightforward approach to
Scheme 1. Diamination of terminal olefins.
vicinal diamines, which are contained in a variety of biological-
ly and chemically significant molecules.[1] A number of effective
metal-mediated[2,3] and metal-catalyzed[3c,4–10] diamination pro-
cesses have been reported. In our own studies, we have devel-
oped Pd0[11,12] and CuI-catalyzed[13] diaminations of olefins
using di-tert-butyldiaziridinone (1)[14] as nitrogen source. When
terminal olefin 2 was used as substrate, the diamination with
Pd0 and diaziridinone 1 occurred at allylic and homoallylic car-
bons (Scheme 1).[12] This process likely proceeded via dehydro-
genation of the terminal olefin to form diene intermediate 3,
which was subsequently diaminated in situ to give product
4.[12] In our continuing efforts to explore the reactivity of diazir-
idinone and expand its synthetic utility, we have found that
imidazolin-2-one 7 can be obtained when terminal olefin 5
was treated with 1 and CuBr, likely via a sequential diamination
and dehydrogenation process (Scheme 1). Imidazolin-2-ones
Figure 1. Imidazolinone-containing biologically active compounds.
are important functional moieties present in various biological-
ly active compounds,[15] such as dopamine D4 receptor antago-
nist,[15a] antibacterial MurB inhibitors,[15b] CGRP receptor antago-
nist,[15d] and antitumor agents[15g] (Figure 1). Imidazolin-2-ones
Our initial diamination studies were carried out with styrene
can generally be synthesized by the cyclization of a-amino car-
bonyl compounds, propargylic ureas, and related com-
pounds,[15,16] or by further derivatization of imidazolin-2-
ones.[17] Herein we report our preliminary studies on the CuI-
catalyzed sequential diamination and dehydrogenation process
of terminal olefins.
(5a) as test substrate and di-tert-butyldiaziridinone (1) as nitro-
gen source under various conditions. As shown in Table 1, no
reaction was observed in many cases (Table 1, entries 1–7).
However, when styrene was treated with 10 mol% CuCl and
3.5 equiv of 1 in CH3CN at RT for 9 h, imidazolin-2-one 7a, in-
stead of diamination product 6a, was formed as major product
and isolated in 59% yield (Table 1, entry 8; the X-ray structure
of 7a is shown in Figure 2). The formation of 7a was some-
what unexpected. A slightly higher yield (63%) was obtained
for 7a with CuBr (Table 1, entry 11), and the yield was in-
creased to 85% by slow addition of 1 (Table 1, entry 12).
[a] Dr. Y. Zhu, Prof. Dr. Y. Shi
Department of Chemistry, Colorado State University
Fort Collins, CO 80523 (USA)
The diamination–dehydrogenation process can be extended
to various para-, meta-, ortho-, and disubstituted styrenes, pro-
Supporting information for this article is available on the WWW under
http://dx.doi.org/10.1002/chem.201404381.
Chem. Eur. J. 2014, 20, 1 – 5
1
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
&